GetTopicDetailResponse(id=c813e7505b, topicName=FXR激動劑, introduction=FXR激動劑, content=null, image=null, comments=4, allHits=1105, url=https://h5.medsci.cn/topic?id=7750, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=94841, tagList=[TagDto(tagId=94841, tagName=FXR激動劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1936926, encodeId=31d11936926a1, content=<a href='/topic/show?id=c813e7505b' target=_blank style='color:#2F92EE;'>#FXR激動劑#</a>, objectTitle=J Hepatol：口服FXR激動劑EDP??-305治療非酒精性脂肪性肝炎的療效, objectType=article, longId=220041, objectId=456022004188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=456022004188, replyNumber=0, likeNumber=89, createdTime=2022-04-04, rootId=0, userName=ms1692810954239974, userId=0e3a2500177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=456022004188, moduleTitle=J Hepatol：口服FXR激動劑EDP??-305治療非酒精性脂肪性肝炎的療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=456022004188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1936925, encodeId=2f4d193692546, content=<a href='/topic/show?id=c813e7505b' target=_blank style='color:#2F92EE;'>#FXR激動劑#</a>, objectTitle=FXR激動劑ASC42治療NASH：美國FDA已批準(zhǔn)IND, objectType=article, longId=202037, objectId=84d120203ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d120203ed5, replyNumber=0, likeNumber=84, createdTime=2021-05-24, rootId=0, userName=ms1692810954239974, userId=0e3a2500177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d120203ed5, moduleTitle=FXR激動劑ASC42治療NASH：美國FDA已批準(zhǔn)IND, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=84d120203ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1936924, encodeId=46ec193692434, content=<a href='/topic/show?id=c813e7505b' target=_blank style='color:#2F92EE;'>#FXR激動劑#</a>, objectTitle=Enanta宣布其FXR激動劑EDP-305治療非酒精性脂肪性肝炎的臨床研究積極成果, objectType=article, longId=180093, objectId=cf0518009397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0518009397, replyNumber=0, likeNumber=153, createdTime=2020-06-13, rootId=0, userName=ms1692810954239974, userId=0e3a2500177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0518009397, moduleTitle=Enanta宣布其FXR激動劑EDP-305治療非酒精性脂肪性肝炎的臨床研究積極成果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cf0518009397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1936923, encodeId=507e193692373, content=<a href='/topic/show?id=c813e7505b' target=_blank style='color:#2F92EE;'>#FXR激動劑#</a>, objectTitle=Gastroenterology：FXR激動劑不依賴FGF19而使膽汁酸的合成減少, objectType=article, longId=151118, objectId=c4c11511183d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4c11511183d, replyNumber=0, likeNumber=79, createdTime=2019-04-09, rootId=0, userName=ms1692810954239974, userId=0e3a2500177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4c11511183d, moduleTitle=Gastroenterology：FXR激動劑不依賴FGF19而使膽汁酸的合成減少, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c4c11511183d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
